Evidence map›Paper›PMID 31315662›Full record

ArticleBMC pharmacology & toxicology2019

Identification of undecylenic acid as EAG channel inhibitor using surface plasmon resonance-based screen of KCNH channels.

Ze-Jun Wang, Purushottam B Tiwari, Aykut Üren, Tinatin I Brelidze

Open access · goldAbstract read
In one paragraph

Article in BMC pharmacology & toxicology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ze-Jun WangDepartment of Pharmacology and Physiology, Georgetown University Medical Center, Washington, DC, USA.
Purushottam B TiwariDepartment of Oncology, Georgetown University Medical Center, Washington, DC, USA.
Aykut ÜrenDepartment of Oncology, Georgetown University Medical Center, Washington, DC, USA.
Tinatin I BrelidzeDepartment of Pharmacology and Physiology, Georgetown University Medical Center, Washington, DC, USA. tib5@georgetown.edu.
Georgetown University Medical Center · USGeorgetown University · US

Funding

Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI STEPHEN W BYERS · 1990 to 2026
$71.5M
KCNH channel regulation by intracellular ligandsR01GM124020 · NIGMS · GEORGETOWN UNIVERSITY · PI BRELIDZE, TINATIN I · 2018 to 2022
$1.7M
Biacore 4000 High Throughput SystemS10OD019982 · OD · GEORGETOWN UNIVERSITY · PI UREN, AYKUT · 2015 to 2015
$484k
NCI NIH HHS P30 CA051008NIGMS NIH HHS R01 GM124020NIH HHS S10 OD019982ODCDC CDC HHS S10 OD019982
6 · The paper itself

Abstract

backgroundKCNH family of potassium channels is responsible for diverse physiological functions ranging from the regulation of neuronal excitability and cardiac contraction to the regulation of cancer progression. KCNH channels contain a Per-Arn-Sim (PAS) domain in their N-terminal and cyclic nucleotide-binding homology (CNBH) domain in their C-terminal regions. These intracellular domains shape the function of KCNH channels and are important targets for drug development.

methodsHere we describe a surface plasmon resonance (SPR)-based screening method aimed in identifying small molecule binders of PAS and CNBH domains for three KCNH channel subfamilies: ether-à-go-go (EAG), EAG-related gene (ERG), and EAG-like K+ (ELK). The method involves purification of the PAS and CNBH domains, immobilization of the purified domains on the SPR senor chip and screening small molecules in a chemical library for binding to the immobilized domains using changes in the SPR response as a reporter of the binding. The advantages of this method include low quantity of purified PAS and CNBH domains necessary for the implementation of the screen, direct assessment of the small molecule binding to the PAS and CNBH domains and easiness of assessing KCNH subfamily specificity of the small molecule binders.

resultsUsing the SPR-based method we screened the Spectrum Collection Library of 2560 compounds against the PAS and CNBH domains of the three KCNH channel subfamilies and identified a pool of small molecules that bind to the PAS or CNBH domains. To further evaluate the effectiveness of the screen we tested the functional effect of one of the identified mEAG PAS domain specific small molecule binders on currents recorded from EAG channels. Undecylenic acid inhibited currents recorded from EAG channels in a concentration-dependent manner with IC50 of ~ 1 μM.

conclusionOur results show that the SPR-based method is well suited for identifying small molecule binders of KCNH channels and can facilitate drug discovery for other ion channels as well.

Indexed as

AnimalsDrug DiscoveryEther-A-Go-Go Potassium ChannelsHumansMiceOocytesPotassium Channel BlockersProtein DomainsSmall Molecule LibrariesSurface Plasmon ResonanceUndecylenic AcidsXenopus laevisEther-A-Go-Go Potassium ChannelsPotassium Channel BlockersSmall Molecule Librariesundecylenic acidUndecylenic AcidsCNBH domainDrug screeningPAS domain

Identifiers

PMID31315662
PMCPMC6637479
OpenAlexW2958784094

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.